This Exploratory Medical Device Study Evaluated the Arrhythmia Diagnostic Yield of MEMO Patch V2, a Wearable Patch-type Electrocardiographic Monitor, in Adults With Suspected Arrhythmia Who Presented With Symptoms Such as Palpitations or Dizziness, or Who Had Cryptogenic Ischemic Stroke or Transient

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

Also called NCT07722026

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 150 participants (enrolled count) (from the registry)
Sponsor
HUINNO Co., Ltd (from the registry)
Registry
  • NCT NCT07722026
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT07722026. Allocation not applicable; no masking; primary purpose diagnostic. Start 2021-09-01 (actual); primary completion 2022-07-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
This Exploratory Medical Device Study Evaluated the Arrhythmia Diagnostic Yield of MEMO Patch V2, a Wearable Patch-type Electrocardiographic Monitor, in Adults With Suspected Arrhythmia Who Presented With Symptoms Such as Palpitations or Dizziness, or Who Had Cryptogenic Ischemic Stroke or Transient
Condition
Suspected Arrhythmia
Condition
Palpitations
Condition
Dizziness
Condition
Cryptogenic Ischemic Stroke
Intervention (Device)
MEMO Patch V2
Intervention (Device)
24-Hour Holter Monitor
Lead sponsor
HUINNO Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct07722026
Content hash
ae83d40270765ae29a13670b2f03c1c32f01f3ff4af2f64b936895b6a283f54b